Skip to main content
OpenTrials
Completed

NCT Number: NCT06094114

Evaluation of VDD Leadless Pacing System During Exercise

The study is a non-randomized, active prospective observational study permitting to report the behavior of Micra AV pacemaker during an exercise.

Only patients who were previously implanted with a Micra MC1AVR01 can be enrolled in the study. Exercise test is part of the standard clinical care practice for this patients population during the first year follow-up.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospitals of Leuven

Leuven, 3000, Belgium

About this study

The purpose of this observational study is to obtain additional data on behavior and safety of the Micra MC1AVR01 during exercise:

  • Characterize the atrial detection rate/A4 amplitude by a ventricular Micra AV (Micra MC1AVR01) at rest and during exercise
  • Characterize the AV synchrony percentage provided by the Micra AV during exercise.
  • Confirm the safety of the Micra AV during exercise

Only patients who were previously implanted with a Micra MC1AVR01 can be enrolled in the study. All subjects provide signed and dated consent that he/she is willing and able to comply with the protocol.

Retrospective patients enrollment is allowed to facilitate a more rapid performance assessment in patients previously implanted with a Micra AV for whom an exercise test has already been performed.

Exercise test The Micra AV permits AV synchronous pacing mode up to a maximal sinus rate of 115/min. Exercise test will therefore be performed up to a maximal heart rate of 115/min. The test will be stopped by the patient (depending on his/her ability/symptoms such as: fatigue, dyspnea, leg pain,..) or by the cardiologist if a maximal heart rate of 115 beats per minute is reached.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients previously implanted with a Micra MC1AVR01
  • Signed and dated consent (patient confirms that he/she is willing and able to comply with the protocol)
  • Patient is physically able to perform an exercise test (cycle test).

Retrospective patients enrolment is allowed to facilitate a more rapid performance assessment in patients previously implanted with a Micra AV for whom an exercise test has already been performed.

Co-enrolment in the Micra AV post-approvals study is allowed.

Exclusion criteria

  • Frail patient unable to perform an exercise test (cycle test).

Treatment and study plan

pacemaker follow-up

Device

Performance of an exercise test in patients previously implanted with Micra AV

Other names: Micra AV

Primary outcomes

  1. Characterize the atrial detection rate/A4 amplitude by a ventricular Micra AV (Micra MC1AVR01) at rest and during exercise

    Time frame: Exercise test is performed during the first year following the Micra implantation

    Characterize the atrial detection rate/A4 amplitude by a ventricular Micra AV (Micra MC1AVR01) at rest and during exercise

  2. Characterize the AV synchrony percentage provided by the Micra AV during exercise.

    Time frame: Exercise test is performed during the first year following the Micra implantation

    Characterize the AV synchrony percentage provided by the Micra AV during exercise.

  3. Confirm the safety of the Micra AV during exercise

    Time frame: Exercise test is performed during the first year following the Micra implantation

    Confirm the safety of the Micra AV during exercise confirmed by the absence of (1) pauses exceeding 2 paced cardiac cycles and (2) oversensing induced tachyarrhythmia exceeding 130 bpm.

Sponsors and collaborators

Lead sponsor

Universitaire Ziekenhuizen KU Leuven

Other

Collaborators

  • Medtronics, Inc.

Registry information

Official study title

Evaluation of Atrio-ventricular Synchronous Pacing Rate During Exercise Test in Patients With a VDD Leadless Pacing System (Micra AV)

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Oct 23, 2023
Registry last updated
Oct 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.